These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 24106407

  • 1. Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma.
    Kim SW, Lim DH, Ahn YC, Kim WS, Kim SJ, Ko YH, Kim KM.
    World J Gastroenterol; 2013 Sep 28; 19(36):6062-8. PubMed ID: 24106407
    [Abstract] [Full Text] [Related]

  • 2. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, Crump M.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1258-64. PubMed ID: 11483337
    [Abstract] [Full Text] [Related]

  • 3. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S, Matsumoto T, Suekane H, Nakamura S, Matsumoto H, Esaki M, Yao T, Iida M.
    Cancer; 2005 Aug 01; 104(3):532-40. PubMed ID: 15937928
    [Abstract] [Full Text] [Related]

  • 4. A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
    Abe S, Oda I, Inaba K, Suzuki H, Yoshinaga S, Nonaka S, Morota M, Murakami N, Itami J, Kobayashi Y, Maeshima AM, Saito Y.
    Jpn J Clin Oncol; 2013 Sep 01; 43(9):917-22. PubMed ID: 23878345
    [Abstract] [Full Text] [Related]

  • 5. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M, Tari A, Kitadai Y, Matsumoto H, Nagaya T, Kamoshida T, Watanabe N, Chiba T, Origasa H, Asaka M, JAPAN GAST Study Group.
    Gut; 2012 Apr 01; 61(4):507-13. PubMed ID: 21890816
    [Abstract] [Full Text] [Related]

  • 6. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M, Copie-Bergman C, Traulle C, Lavergne-Slove A, Brousse N, Flejou JF, de Mascarel A, Hemery F, Gaulard P, Delchier JC, Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Am J Gastroenterol; 2002 Feb 01; 97(2):292-7. PubMed ID: 11866264
    [Abstract] [Full Text] [Related]

  • 7. Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial.
    Schmelz R, Miehlke S, Thiede C, Brueckner S, Dawel M, Kuhn M, Ruskoné-Formestraux A, Stolte M, Jentsch C, Hampe J, Morgner A.
    J Gastroenterol; 2019 May 01; 54(5):388-395. PubMed ID: 30327875
    [Abstract] [Full Text] [Related]

  • 8. Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up.
    Ruskoné-Fourmestraux A, Matysiak-Budnik T, Fabiani B, Cervera P, Brixi H, Le Malicot K, Nion-Larmurier I, Fléjou JF, Hennequin C, Quéro L, Groupe d’Étude des Lymphomes Digestifs (GELD) & Fédération Francophone de Cancérologie Digestive.
    Radiother Oncol; 2015 Oct 01; 117(1):178-82. PubMed ID: 26395311
    [Abstract] [Full Text] [Related]

  • 9. Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association.
    Park S, Ahn S, Hong M, Ko YH.
    Hum Pathol; 2017 Jan 01; 59():113-119. PubMed ID: 27697589
    [Abstract] [Full Text] [Related]

  • 10. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
    Sugimoto M, Kajimura M, Shirai N, Furuta T, Kanaoka S, Ikuma M, Sato Y, Hishida A.
    Intern Med; 2006 Jan 01; 45(6):405-9. PubMed ID: 16617193
    [Abstract] [Full Text] [Related]

  • 11. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
    Pinnix CC, Gunther JR, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Amini B, Neelapu S, Lee HJ, Westin J, Fowler N, Nastoupil L, Dabaja B.
    Int J Radiat Oncol Biol Phys; 2019 Jun 01; 104(2):447-455. PubMed ID: 30769175
    [Abstract] [Full Text] [Related]

  • 12. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS, Wang HP, Kuo SH, Sheu BS, Jan CM, Wang WM, Wang TE, Wu CW, Chen CL, Su IJ, Whang-Peng J, Cheng AL.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1345-53. PubMed ID: 16174856
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ, Kim N, Paik JH, Kim JM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC.
    Helicobacter; 2013 Jun 21; 18(3):197-205. PubMed ID: 23305046
    [Abstract] [Full Text] [Related]

  • 14. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Gong EJ, Ahn JY, Jung HY, Park H, Ko YB, Na HK, Jung KW, Kim do H, Lee JH, Choi KD, Song HJ, Lee GH, Kim JH.
    Gut Liver; 2016 Sep 15; 10(5):706-13. PubMed ID: 27114423
    [Abstract] [Full Text] [Related]

  • 15. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study.
    Andriani A, Miedico A, Tedeschi L, Patti C, Di Raimondo F, Leone M, Schinocca L, Romanelli A, Bonanno G, Linea C, Giustini M, Hassan C, Cottone M, Zullo A.
    Dig Liver Dis; 2009 Jul 15; 41(7):467-73. PubMed ID: 18945654
    [Abstract] [Full Text] [Related]

  • 16. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
    Chen LT, Lin JT, Shyu RY, Jan CM, Chen CL, Chiang IP, Liu SM, Su IJ, Cheng AL.
    J Clin Oncol; 2001 Nov 15; 19(22):4245-51. PubMed ID: 11709568
    [Abstract] [Full Text] [Related]

  • 17. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T, Seto M, Tajika M, Kawai H, Yokoi T, Yatabe Y, Nakamura S.
    Am J Gastroenterol; 2008 Jan 15; 103(1):62-70. PubMed ID: 17894851
    [Abstract] [Full Text] [Related]

  • 18. Should All Patients With Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Receive Antibiotic Eradication Therapy for Helicobacter pylori?
    Laoruangroj C, Habermann TM, Wang Y, King RL, Lester SC, Thompson CA, Witzig TE.
    JCO Oncol Pract; 2024 Aug 15; 20(8):1103-1108. PubMed ID: 38713887
    [Abstract] [Full Text] [Related]

  • 19. A prospective analysis of efficacy and long-term outcome of radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma.
    Okada H, Takemoto M, Kawahara Y, Nasu J, Takenaka R, Kawano S, Inoue M, Ichimura K, Tanaka T, Shinagawa K, Yoshino T, Yamamoto K.
    Digestion; 2012 Aug 15; 86(3):179-86. PubMed ID: 22907329
    [Abstract] [Full Text] [Related]

  • 20. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G, Martínez Egea A, Sánchez Cuenca J, Onrubia Pintado J, García Lafuente N, Ruiz Gómez F, Coronas Planas M.
    Rev Esp Enferm Dig; 1999 Aug 15; 91(8):541-8. PubMed ID: 10491486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.